Multiple law firms are pushing AeroVironment investors to take action on a securities class action lawsuit that alleges the company concealed critical problems with its government contracts. These firms are specifically calling on investors who lost money during the relevant period to consider seeking the role of lead plaintiff—a position that carries real influence over how the case is managed and settled. The underlying allegations paint a picture of a company that downplayed mounting challenges with its Space Force SCAR program contract, a major revenue driver, while reassuring shareholders that business was solid.
The lawsuit centers on a compressed timeline of disclosure that hurt shareholders hard. Between a government stop work order in January 2026 and an announcement about contract competition in March 2026, the company finally admitted to a $151.3 million goodwill impairment and contract termination—details that investors say they should have known about sooner. For anyone who bought or held AeroVironment stock between June 25, 2025 and March 10, 2026, the deadline to seek lead plaintiff status is July 27, 2026, giving investors roughly a month to decide whether to get involved.
Table of Contents
- What Is the SCAR Program and Why Did AeroVironment’s Loss Matter?
- The Disclosure Timeline and Concealment Allegations
- Financial Impact and the $151.3 Million Impairment
- How to Participate and the Lead Plaintiff Deadline
- Core Allegations and What They Reveal About Corporate Disclosure Failures
- Multiple Law Firms and Investor Representation Options
- Investor Eligibility and Practical Next Steps
- Frequently Asked Questions
What Is the SCAR Program and Why Did AeroVironment’s Loss Matter?
The Space Force’s Small Class Aerial Robot (SCAR) program represents the kind of government contract that can make or break a defense contractor. For AeroVironment, this program was significant enough that losing it triggered a $151.3 million goodwill impairment—a massive write-down that signals the company had seriously overstated what the contract was worth. Goodwill impairment occurs when a company realizes that an asset (in this case, the value it assigned to the SCAR program relationship) isn’t actually worth what it paid or expected.
The public discovery that the Space Force was reopening the contract for competition on March 2, 2026 essentially revealed that AeroVironment’s competitive position was weaker than executives had suggested to investors. For a company in the aerospace and defense sector, government contracts aren’t just one revenue stream among many—they often represent the foundation of the business. When a single program can justify over $150 million in impairment charges, it means investors may have been relying on financial forecasts that included contributions from this contract that never materialized. The timing matters because AeroVironment had months—from the January 20, 2026 government stop work order through early March—to alert investors that something serious was wrong, but apparently did not.
The Disclosure Timeline and Concealment Allegations
The securities class action alleges that AeroVironment and its executives made false and misleading statements by concealing the imminent competition for the SCAR program while simultaneously overstating the company’s business and financial prospects. this is not a case where the company lost a bid unexpectedly; it’s a case where the company allegedly knew competition was coming and didn’t tell shareholders. The class period runs from June 25, 2025 through March 10, 2026—nine months during which investors may have made decisions based on incomplete information.
A critical limitation of securities class actions is that they typically move slowly, and by the time a case settles, the original investors may have already sold their shares and moved on to other investments. Even if a settlement is reached, the per-share recovery is often modest compared to the total losses shareholders suffered. For example, a shareholder who held 1,000 shares and lost $50 per share (a $50,000 loss) might receive a recovery measured in the hundreds of dollars after legal fees are paid, depending on the settlement size and how many other claimants are involved. The real value of participation often lies in preventing similar concealment in the future, not in recovering full losses.
Financial Impact and the $151.3 Million Impairment
When AeroVironment disclosed the goodwill impairment and contract termination on March 10, 2026, the stock responded with a significant decline. This is a common pattern in defense contracting: once a major contract loss becomes public knowledge, investors immediately reassess the company’s earnings potential, and the stock price adjusts downward. The impairment charge itself—$151.3 million—is an accounting write-down that doesn’t directly affect cash flow but signals management’s acknowledgment that previous valuations were wrong.
What makes this impairment particularly relevant to the securities lawsuit is the scale relative to the company’s overall market capitalization. If AeroVironment’s market cap at the time was in the range of several billion dollars, a $151.3 million write-down is material but not catastrophic; however, if the company is smaller or if the SCAR program represented a disproportionate share of expected future profits, the impairment carries more weight. The stop work order issued January 20, 2026 would have been known internally to AeroVironment’s leadership, creating an opportunity to inform investors before the March 2 Space Force announcement made it impossible to hide the problem any longer.
How to Participate and the Lead Plaintiff Deadline
The law firms involved—including Faruqi & Faruqi LLP, Kirby McInerney LLP, Bernstein Liebhard LLP, and Robbins LLP—are actively recruiting investors to participate in the lawsuit. Seeking lead plaintiff status is optional and carries a specific deadline: July 27, 2026. Lead plaintiff status grants an investor a seat at the table in managing the lawsuit, which can include input on settlement negotiations and representation in court filings.
An investor who wants to pursue lead plaintiff status typically needs to show that they have a significant financial stake in the outcome and are willing to serve in that capacity throughout the litigation. Here’s an important tradeoff: a lead plaintiff does gain influence over major case decisions, but they also become the public face of the lawsuit and may be called upon to provide detailed testimony or discovery materials. An investor who simply wants to participate in any eventual recovery without taking on this visibility and responsibility can do so regardless of whether they seek lead plaintiff status—claiming lead plaintiff status is optional but doesn’t affect the right to benefit from a settlement. Many investors find that simply notifying their broker or the claims administrator that they hold eligible securities is sufficient to preserve their rights, without the additional burden of lead plaintiff duties.
Core Allegations and What They Reveal About Corporate Disclosure Failures
The securities class action charges that AeroVironment and its executives made false and misleading statements regarding business prospects while knowingly concealing information about the SCAR program’s vulnerability. In regulatory and legal terms, this kind of claim rests on the idea that executives had material nonpublic information—the government’s growing dissatisfaction with AeroVironment’s performance or the pending contract reopening—and failed to disclose it. The stop work order itself would certainly qualify as material nonpublic information that should have triggered disclosure obligations. One limitation of securities litigation is that proving intent to deceive is difficult.
Companies often argue that disclosure failures were innocent oversights or the result of internal miscommunication, not deliberate fraud. Courts have set a high bar for securities claims, requiring evidence that executives knew statements were false at the time they made them, not just that events later proved forecasts wrong. The timespan between January 20 (stop work order) and March 10 (disclosure) is compact enough that it suggests a deliberate concealment strategy, but the final judgment on that question rests with the courts. A warning for investors evaluating their participation: even a successful securities class action typically results in a cash settlement paid from company insurance, not admission of wrongdoing or criminal sanctions against executives.
Multiple Law Firms and Investor Representation Options
Four major law firms—Faruqi & Faruqi, Kirby McInerney, Bernstein Liebhard, and Robbins—are actively representing AeroVironment shareholders in this action. Investors who received communications from one or more of these firms should be aware that working with any of them preserves their rights to participate in the lawsuit. Law firms in securities class actions typically work on a contingency basis, meaning they collect fees only from any settlement recovery, not from individual investors.
This structure removes the barrier to participation for investors who lack resources to pay hourly rates, but it also means law firms have an incentive to settle quickly rather than pursue the case to trial. An investor’s choice among these firms, if they decide to work with one, may depend on past relationships, reputation, or which firm makes first contact. Because the lawsuit is a class action, selecting one firm does not exclude participation in the final recovery, and all investors in the designated class are entitled to share in any settlement regardless of which firm they communicated with. The key step is ensuring that your broker or the claims administrator has a record that you held AeroVironment securities during the class period (June 25, 2025 through March 10, 2026).
Investor Eligibility and Practical Next Steps
Eligibility for the class action is straightforward: investors who purchased or acquired AeroVironment securities during the class period of June 25, 2025 through March 10, 2026 may be eligible to participate. This includes purchases through brokerage accounts, retirement accounts, employer stock purchase plans, or direct ownership. The deadline to seek lead plaintiff status is July 27, 2026, meaning that investors who want to actively participate in case management should move quickly to notify the law firms or file a motion with the court.
For investors simply seeking to preserve their rights without taking on lead plaintiff duties, the practical step is to retain documentation of their holdings and transactions—brokerage statements showing the date and quantity of purchases, and current statements showing whether the shares were still held on March 10, 2026 or sold prior to that date. If shares were sold before the impairment announcement on March 10, the investor may have a claim for damages based on selling at what they allege was an artificially depressed price due to nondisclosure. The law firms have published their contact information in press releases and announcements, allowing investors to reach out with questions about eligibility or next steps.
Frequently Asked Questions
What is the lead plaintiff deadline for AeroVironment investors?
The deadline to seek lead plaintiff status in the class action is July 27, 2026. After this date, investors can still participate in any settlement, but they cannot pursue the lead plaintiff role.
Does choosing not to seek lead plaintiff status affect my recovery rights?
No. Deciding not to pursue lead plaintiff designation does not impact your ability to participate in any class recovery or settlement. Lead plaintiff status is optional and is primarily relevant for investors who want direct involvement in managing the lawsuit.
Which law firms are representing AeroVironment shareholders?
Multiple firms are involved, including Faruqi & Faruqi LLP, Kirby McInerney LLP, Bernstein Liebhard LLP, and Robbins LLP. Working with any of them preserves your class action rights.
What is the class period for eligible investors?
The class period runs from June 25, 2025 through March 10, 2026. Investors who purchased or acquired AeroVironment securities during this timeframe may be eligible to participate.
What triggered the securities lawsuit?
The lawsuit was triggered by AeroVironment’s failure to disclose problems with the Space Force SCAR program contract before announcing a $151.3 million goodwill impairment on March 10, 2026, following a government stop work order in January and a contract reopening announcement in March.
What should I do if I held AeroVironment stock during the class period?
Preserve documentation of your purchases and holdings, and contact one of the law firms listed in press releases to confirm your eligibility and preserve your rights to participate in any settlement.